Inter- and intra-patient heterogeneity of response and progression to targeted therapy in metastatic melanoma von Menzies, Alexander M, Haydu, Lauren E, Carlino, Matteo S, Azer, Mary W F, Carr, Peter J A, Kefford, Richard F, Long, Georgina V

Volltext

Patterns of response and progression in patients with BRAF‐mutant melanoma metastatic to the brain who were treated with dabrafenib von Azer, Mary W. F ., Menzies, Alexander M., Haydu, Lauren E., Kefford, Richard F., Long, Georgina V.

Volltext

The nature and management of metastatic melanoma after progression on BRAF inhibitors: Effects of extended BRAF inhibition von Chan, Matthew M. K., Haydu, Lauren E., Menzies, Alexander M., Azer, Mary W. F., Klein, Oliver, Lyle, Megan, Clements, Arthur, Guminski, Alexander, Kefford, Richard F., Long, Georgina V.

Volltext

Immune-related adverse events and nivolumab outcomes in non-small cell lung cancer patients: A multi-institutional, retrospective cohort study von Moor, Rebecca Jane, Roberts, Kate Elizabeth, Mason, Robert, Gunawan, Ben, Feng, Sophie, Hong, Jun Hee, Von Itzstein, Mitchell, Hughes, Brett Gordon Maxwell, Lwin, Zarnie, Jain, Vikram Kumar, Bigby, Kieron James, Azer, Mary W. F., Sanmugarajah, Jasotha, O'Byrne, Kenneth John

Volltext

Clinical characteristics and survival of BRAF-mutant (BRAF+) metastatic melanoma patients (pts) treated with BRAF inhibitor (BRAFi) dabrafenib or vemurafenib beyond disease progres... von Chan, Matthew, Haydu, Lauren, Menzies, Alexander M., Azer, Mary W. F., Klein, Oliver, Guminski, Alexander, Kefford, Richard, Long, Georgina

Volltext

Patterns of progression in patients (pts) with V600 BRAF-mutated melanoma metastatic to the brain treated with dabrafenib (GSK2118436) von Azer, Mary W. F., Menzies, Alexander M., Haydu, Lauren, Kefford, Richard, Long, Georgina V.

Volltext